VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer <i>in vivo</i>

Guangbo Kang(Tianjin University), He Huang(Tianjin University), Ruowei Li(Tianjin University), Xin Cheng(Tianjin University), He Ren(Qingdao University), Zixuan Bai(Tianjin University), Bo Yuan(University Medical Center Utrecht), Jiewen Wang(Thermal Power Research Institute), Min Hu, Yasmine Balan(University of Ottawa)
Cancer Biology and Medicine
January 1, 2021
Cited by 19


Related Papers